Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Argent Biopharma LtdTelephone
61.8.6382.3390
Address
Suite 1 295 Rokeby Road Subiaco, Western Australia (WA) 6008
Description
Argent BioPharma Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Roby Zomer on October 21, 2005 and is headquartered in Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.15 - 2.0
Trade Value (12mth)
AU$2,940.00
1 week
-8.51%
1 month
32.31%
YTD
-14%
1 year
-71.33%
All time high
4950.00
EPS 3 yr Growth
-94.30%
EBITDA Margin
%
Operating Cashflow
-$15m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-35.00
Quick Ratio
0.20
Shares on Issue (Fully Dilluted)
45m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
15 October 24 |
Application for quotation of securities - RGT
×
Application for quotation of securities - RGT |
15 October 24 |
Application for quotation of securities - RGT
×
Application for quotation of securities - RGT |
15 October 24 |
Notification regarding unquoted securities - RGT
×
Notification regarding unquoted securities - RGT |
15 October 24 |
s708A Cleansing Notice
×
s708A Cleansing Notice |
15 October 24 |
Change of Director's Interest Notice - RZ
×
Change of Director's Interest Notice - RZ |
15 October 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
09 October 24 |
Refinancing of Convertible Security Agreement
×
Refinancing of Convertible Security Agreement |
09 October 24 |
Application for quotation of securities - RGT
×
Application for quotation of securities - RGT |
09 October 24 |
s708A Cleansing Notice
×
s708A Cleansing Notice |
01 October 24 |
Results of Meeting
×
Results of Meeting |
30 September 24 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
30 September 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
25 September 24 |
Date of AGM and Closing Date for Director Nominations
×
Date of AGM and Closing Date for Director Nominations |
23 September 24 |
Delisting Update
×
Delisting Update |
12 September 24 |
Change of Director's Interest Notice - RZ
×
Change of Director's Interest Notice - RZ |
10 September 24 |
CannEpil - Technical Overview
×
CannEpil - Technical Overview |
09 September 24 |
CimetrA - Technical Overview
×
CimetrA - Technical Overview |
06 September 24 |
Company Presentation
×
Company Presentation |
30 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
27 August 24 |
Notice of General Meeting/Proxy Form
×
Notice of General Meeting/Proxy Form |
27 August 24 |
Letter from the CEO
×
Letter from the CEO |
21 August 24 |
SINTEF Collaboration for Advanced Chronic Wound Management
×
SINTEF Collaboration for Advanced Chronic Wound Management |
15 August 24 |
Voluntary Delisting from ASX
×
Voluntary Delisting from ASX |
13 August 24 |
Trading Halt
×
Trading Halt |
30 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.